Literature DB >> 24900250

Kinase inhibition by deoxy analogues of the resorcylic lactone L-783277.

Marc Liniger1, Christian Neuhaus1, Tatjana Hofmann1, Luca Fransioli-Ignazio1, Michel Jordi1, Peter Drueckes2, Jörg Trappe2, Doriano Fabbro2, Karl-Heinz Altmann1.   

Abstract

The natural product L-783277 is a resorcylic lactone type covalent kinase inhibitor. We have prepared the 5'-deoxy analogue of L-783277 (1) in a stereoselective fashion. Remarkably, this analogue retains almost the full kinase inhibitory potential of natural L-783277, with low nanomolar IC50 values against the most sensitive kinases, and it exhibits essentially the same selectivity profile (within the panel of 39 kinases investigated). In contrast, removal of both the 4'- and the 5'-hydroxyl groups leads to a more significant reduction in kinase inhibitory activity and so does a change in the geometry of the C7'-C8' double bond in 1 from Z to E. These findings offer new perspectives for the design of second generation resorcylic lactone-based kinase inhibitors.

Entities:  

Keywords:  Cancer; SAR; irreversible inhibitor; kinase inhibitor; natural product; resorcylic lactone (RL); stereoselective synthesis

Year:  2010        PMID: 24900250      PMCID: PMC4018056          DOI: 10.1021/ml1001807

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN: 1948-5875            Impact factor:   4.345


  23 in total

1.  Discovery of an in vitro and in vivo potent resorcylic lactone analog of LL-Z1640-2 as anti-inflammatory lead, II.

Authors:  Yongchun Shen; Hong Du; Makoto Kotake; Tomohiro Matsushima; Masaki Goto; Hiroshi Shirota; Fabian Gusovsky; Xiangyi Li; Yimin Jiang; Shawn Schiller; Mark Spyvee; Heather Davis; Zhiyi Zhang; Robert Pelletier; Megumi Ikemori-Kawada; Yoshiyuki Kawakami; Atsushi Inoue; Yuan Wang
Journal:  Bioorg Med Chem Lett       Date:  2010-04-09       Impact factor: 2.823

2.  Semisynthesis and cytotoxicity of hypothemycin analogues.

Authors:  Brian R Hearn; Kurt Sundermann; Jonah Cannoy; Daniel V Santi
Journal:  ChemMedChem       Date:  2007-11       Impact factor: 3.466

Review 3.  Chemistry and biology of resorcylic acid lactones.

Authors:  Nicolas Winssinger; Sofia Barluenga
Journal:  Chem Commun (Camb)       Date:  2006-09-25       Impact factor: 6.222

4.  E6201 [(3S,4R,5Z,8S,9S,11E)-14-(ethylamino)-8, 9,16-trihydroxy-3,4-dimethyl-3,4,9,19-tetrahydro-1H-2-benzoxacyclotetradecine-1,7(8H)-dione], a novel kinase inhibitor of mitogen-activated protein kinase/extracellular signal-regulated kinase kinase (MEK)-1 and MEK kinase-1: in vitro characterization of its anti-inflammatory and antihyperproliferative activities.

Authors:  Masaki Goto; Jesse Chow; Kenzo Muramoto; Ken-ichi Chiba; Satoshi Yamamoto; Masanori Fujita; Hiroshi Obaishi; Kenji Tai; Yoshiharu Mizui; Isao Tanaka; Donna Young; Hua Yang; Yuan J Wang; Hiroshi Shirota; Fabian Gusovsky
Journal:  J Pharmacol Exp Ther       Date:  2009-08-14       Impact factor: 4.030

5.  Conformational analyses and MO studies of f152A1 and its analogues as potent protein kinase inhibitors.

Authors:  Megumi Ikemori-Kawada; Takatoshi Kawai; Masaki Goto; Yuan John Wang; Yoshiyuki Kawakami
Journal:  J Chem Inf Model       Date:  2009-12       Impact factor: 4.956

6.  Molecular editing of kinase-targeting resorcylic acid lactones (RAL): Fluoroenone RAL.

Authors:  Rajamalleswaramma Jogireddy; Sofia Barluenga; Nicolas Winssinger
Journal:  ChemMedChem       Date:  2010-05-03       Impact factor: 3.466

Review 7.  Factors underlying sensitivity of cancers to small-molecule kinase inhibitors.

Authors:  Pasi A Jänne; Nathanael Gray; Jeff Settleman
Journal:  Nat Rev Drug Discov       Date:  2009-07-24       Impact factor: 84.694

Review 8.  Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer.

Authors:  P J Roberts; C J Der
Journal:  Oncogene       Date:  2007-05-14       Impact factor: 9.867

9.  PDGFRA activating mutations in gastrointestinal stromal tumors.

Authors:  Michael C Heinrich; Christopher L Corless; Anette Duensing; Laura McGreevey; Chang-Jie Chen; Nora Joseph; Samuel Singer; Diana J Griffith; Andrea Haley; Ajia Town; George D Demetri; Christopher D M Fletcher; Jonathan A Fletcher
Journal:  Science       Date:  2003-01-09       Impact factor: 47.728

10.  A resorcylic acid lactone, 5Z-7-oxozeaenol, prevents inflammation by inhibiting the catalytic activity of TAK1 MAPK kinase kinase.

Authors:  Jun Ninomiya-Tsuji; Taisuke Kajino; Koichiro Ono; Toshihiko Ohtomo; Masahiko Matsumoto; Masashi Shiina; Masahiko Mihara; Masayuki Tsuchiya; Kunihiro Matsumoto
Journal:  J Biol Chem       Date:  2003-03-06       Impact factor: 5.486

View more
  4 in total

1.  Exploring aigialomycin d and its analogues as protein kinase inhibitors for cancer targets.

Authors:  Jin Xu; Anqi Chen; Mei-Lin Go; Kassoum Nacro; Boping Liu; Christina L L Chai
Journal:  ACS Med Chem Lett       Date:  2011-07-17       Impact factor: 4.345

Review 2.  Natural and Synthetic Lactones Possessing Antitumor Activities.

Authors:  Younghoon Kim; Sandip Sengupta; Taebo Sim
Journal:  Int J Mol Sci       Date:  2021-01-21       Impact factor: 6.208

3.  On the Mechanism of Action of Anti-Inflammatory Activity of Hypericin: An In Silico Study Pointing to the Relevance of Janus Kinases Inhibition.

Authors:  Luca Dellafiora; Gianni Galaverna; Gabriele Cruciani; Chiara Dall'Asta; Renato Bruni
Journal:  Molecules       Date:  2018-11-22       Impact factor: 4.411

4.  Media and strain studies for the scaled production of cis-enone resorcylic acid lactones as feedstocks for semisynthesis.

Authors:  Zeinab Y Al Subeh; Huzefa A Raja; Jennifer C Obike; Cedric J Pearce; Mitchell P Croatt; Nicholas H Oberlies
Journal:  J Antibiot (Tokyo)       Date:  2021-06-21       Impact factor: 3.424

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.